Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 5139750, 7 pages
https://doi.org/10.1155/2017/5139750
Research Article

High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report

1Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine, Yonago, Tottori, Japan
2School of Health Science, Tottori University Faculty of Medicine, Yonago, Tottori, Japan
3Department of Regional Medicine, Tottori University Faculty of Medicine, Yonago, Tottori, Japan
4Faculty of Applied Life Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan
5Department of Food and Nutrition, Toita Women’s College, Tokyo, Japan

Correspondence should be addressed to Tsuyoshi Okura; pj.ca.u-irottot.dem@arukho

Received 15 February 2017; Revised 24 March 2017; Accepted 12 April 2017; Published 12 June 2017

Academic Editor: Joseph F. Ndisang

Copyright © 2017 Tsuyoshi Okura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. DeFronzo, “Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM,” Diabetes, vol. 37, no. 6, pp. 667–687, 1988. View at Publisher · View at Google Scholar
  2. Y. Nomi, H. Annaka, S. Sato et al., “Simultaneous quantitation of advanced glycation end products in soy sauce and beer by liquid chromatography-tandem mass spectrometry without ion-pair reagents and derivatization,” Journal of Agricultural and Food Chemistry, vol. 64, no. 44, pp. 8397–8405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. Thorpe and J. W. Baynes, “Maillard reaction products in tissue proteins: new products and new perspectives,” Amino Acids, vol. 25, no. 3-4, pp. 275–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. T. Coughlan, F. Y. Yap, D. C. Tong et al., “Advanced glycation end products are direct modulators of β-cell function,” Diabetes, vol. 60, no. 10, pp. 2523–2532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Forbes, K. C. Sourris, M. P. de Courten et al., “Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects,” Amino Acids, vol. 46, no. 10, pp. 321–326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. C. Tan, S. W. Shiu, Y. Wong, and X. Tam, “Serum advanced glycation end products (AGEs) are associated with insulin resistance,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 5, pp. 488–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” The American Journal of Physiology, vol. 237, no. 3, pp. 214–223, 1979. View at Google Scholar
  8. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. E. S. Kang, Y. S. Yun, S. W. Park et al., “Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea,” Metabolism, vol. 54, no. 2, pp. 206–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Kodama, D. Tojjar, S. Yamada, K. Toda, C. J. Patel, and A. J. Butte, “Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis,” Diabetes Care, vol. 36, no. 6, pp. 1789–1796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Charissou, L. Ait-Ameur, and I. Birlouez-Aragon, “Evaluation of a gas chromatography/mass spectrometry method for the quantification of carboxymethyllysine in food samples,” Journal of Chromatography, vol. 1140, no. 1-2, pp. 189–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar
  13. T. Ohkura, H. Shiochi, Y. Fujioka et al., “20/(fasting C-peptide x fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report,” Cardiovascular Diabetology, vol. 12, no. 1, p. 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Yoshino, M. Tominaga, T. Hirano et al., “The test meal A:A pilot model for the international standard of test meal for an assessment of both postprandial hyperglycemia and hyperlipidemia,” Journal of the Japan Diabetes Society, vol. 49, no. 5, pp. 361–371, 2006. View at Google Scholar
  15. National Institutes of Diabetes and Digestive and Kidney Diseases, “The HbA1c converter,” 1999, http://www.ngsp.org/convert1.asp.
  16. R. Kawamori, M. Matsuhisa, J. Kinoshita et al., “Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non-insulin-dependent diabetes mellitus. AD-4833 Clamp-OGL Study Group,” Diabetes Research and Clinical Practice, vol. 41, no. 1, pp. 35–43, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Tamura, Y. Tanaka, F. Sato et al., “Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3191–3196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shiochi, T. Ohkura, Y. Fujioka et al., “Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study,” Diabetology and Metabolic Syndrome, vol. 6, no. 1, p. 113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Sakurai, Y. Tamura, K. Takeno et al., “Determinants of intramyocellular lipid accumulation after dietary fat loading in non-obese men,” Journal of Diabetes Investigation, vol. 4, no. 4, pp. 310–317, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Sato, Y. Tamura, H. Watada et al., “Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3326–3329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Bonora, S. Kiechl, J. Willeit, and M. Muggeo, “Prevalence of insulin resistance in metabolic disorders: the Bruneck study,” Diabetes, vol. 47, no. 10, pp. 1643–1649, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp,” Diabetes Care, vol. 22, no. 9, pp. 1462–1470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. W. N. Kernan, S. E. Inzucchi, C. M. Viscoli et al., “Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke,” Stroke, vol. 34, no. 6, pp. 1431–1436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. H. S. Seltzer, E. W. Allen, A. L. Herron Jr, and M. T. Brennan, “Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus,” Journal of Clinical Investigation, vol. 46, no. 3, pp. 323–335, 1967. View at Google Scholar
  25. Z. Zhao, C. Zhao, and X. H. Zhang, “Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis,” Endocrinology, vol. 150, no. 6, pp. 2569–2576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Lo, M. H. Chen, W. S. Lee et al., “Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells,” American Journal of Physiology. Endocrinology and Metabolism, vol. 309, no. 10, p. E829-39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. V. C. Luft, B. B. Duncan, M. I. Schmidt et al., “Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC study,” Diabetic Medicine, vol. 33, no. 10, p. 1392, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Muniyappa, S. Lee, H. Chen, and M. J. Quon, “Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage,” American Journal of Physiology. Endocrinology and Metabolism, vol. 294, no. 1, pp. E15–E26, 2008, Review. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Kanauchi, N. Tsujimoto, and T. Hashimoto, “Validation of simple indices to assess insulin sensitivity based on the oral glucose tolerance test in the Japanese population,” Diabetes Research and Clinical Practice, vol. 55, no. 3, pp. 229–235, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. B. de Courten, M. P. de Courten, G. Soldatos et al., “Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial,” The American Journal of Clinical Nutrition, vol. 103, no. 6, pp. 1426–1433, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Vlassara, W. Cai, E. Tripp et al., “Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial,” Diabetologia, vol. 59, no. 10, pp. 2181–2192, 2016. View at Publisher · View at Google Scholar · View at Scopus